These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31926189)

  • 1. Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells.
    John Mary DJS; Sikarwar G; Kumar A; Limaye AM
    Mol Cell Endocrinol; 2020 Mar; 504():110701. PubMed ID: 31926189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
    Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
    Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Manjegowda MC; Gupta PS; Limaye AM
    Gene; 2017 May; 614():65-73. PubMed ID: 28286086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KISS1 is down-regulated by 17beta-estradiol in MDA-MB-231 cells through a nonclassical mechanism and loss of ribonucleic acid polymerase II binding at the proximal promoter.
    Huijbregts L; de Roux N
    Endocrinology; 2010 Aug; 151(8):3764-72. PubMed ID: 20534720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
    Du J; Zhou N; Liu H; Jiang F; Wang Y; Hu C; Qi H; Zhong C; Wang X; Li Z
    PLoS One; 2012; 7(4):e35957. PubMed ID: 22558281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells.
    Lan ZJ; Hu Y; Zhang S; Li X; Zhou H; Ding J; Klinge CM; Radde BN; Cooney AJ; Zhang J; Lei Z
    Breast Cancer Res Treat; 2016 Jul; 158(2):263-76. PubMed ID: 27357812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells.
    Zhang Y; Zhou G; Wang H; Zhang X; Wei F; Cai Y; Yin D
    Oncology; 2006; 71(5-6):446-55. PubMed ID: 17878748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
    Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
    Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERE-independent ERalpha target genes differentially expressed in human breast tumors.
    Glidewell-Kenney C; Weiss J; Lee EJ; Pillai S; Ishikawa T; Ariazi EA; Jameson JL
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):53-9. PubMed ID: 16298037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells.
    Edjekouane L; Benhadjeba S; Jangal M; Fleury H; Gévry N; Carmona E; Tremblay A
    Oncotarget; 2016 Nov; 7(47):77276-77290. PubMed ID: 27764788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
    Tang B; Jiang J
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
    Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
    J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
    Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
    Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.
    Ramaswamy B; Majumder S; Roy S; Ghoshal K; Kutay H; Datta J; Younes M; Shapiro CL; Motiwala T; Jacob ST
    Mol Endocrinol; 2009 Feb; 23(2):176-87. PubMed ID: 19095770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
    Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.